United States:
Health Care Weekly Preview From ML Strategies – Week Of October 2, 2017
To print this article, all you need is to be registered or login on Mondaq.com.
Our colleagues at
ML Strategies have provided their
Health Care Weekly Preview for the week of October 2, 2017.
This week's preview focuses on the wake left by Secretary
Price's exit, including its impact on the administration's
deregulatory agenda. The preview also discusses Congress'
failure to reauthorize a number of health care programs, including
the Children's Health Insurance Program (CHIP), as well as its
failure to address issues related to disproportionate share
hospitals (DSH), special needs plans (SNPs) and community health
centers.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...